Open AccessS218: A PHASE I/II STUDY OF GOLIDOCITINIB, A SELECTIVE JAK1 INHIBITOR, IN REFRACTORY OR RELAPSED PERIPHERAL T CELL LYMPHOMA
Author(s) -
Kim W.S.,
Yoon D.H.,
Song Y.,
Yang H.,
Cao J.,
Ji D.,
Koh Y.,
Jing H.,
Eom H.S.,
Kwak J.Y.,
Lee W.S.,
Lee J.S.,
Shin H.J.,
Jin J.,
Wang M.,
Li J.,
Huang X.,
Deng X.,
Yang Z.,
Zhu J.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000843764.15785.8c
Subject(s) - medicine , peripheral t cell lymphoma , lymphoma , refractory (planetary science) , oncology , gastroenterology , t cell , immunology , immune system , physics , astrobiology